(−)‐Epigallocatechin Gallate Ameliorates Chronic Stress‐Induced Depression‐Like Behavior in Rats by Inhibiting the NF‐κB/Caspase‐1 Signaling Pathway and Reducing IL‐1β and IL‐18 Expression. This evidence concerns the gene IL18 and depressive disorder.